Oral azithromycin in extended dosage schedule for chronic, subclinical Chlamydia pneumoniae infection causing coronary artery disease: a probable cure in sight? Results of a controlled preliminary trial

PURPOSE: Two mega trials have raised the question as to whether the hypothesis that infection plays a role in atherosclerosis is still relevant. This controlled preliminary trial investigated an extended dose of azithromycin in the treatment of Chlamydia pneumoniae infection causing coronary artery...

Descripción completa

Detalles Bibliográficos
Autor principal: Dogra, Jaideep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396117/
https://www.ncbi.nlm.nih.gov/pubmed/22807637
http://dx.doi.org/10.2147/IJGM.S31625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396117/
https://www.ncbi.nlm.nih.gov/pubmed/22807637
http://dx.doi.org/10.2147/IJGM.S31625

Ejemplares similares